"For many years we’ve been leading the cell research market, with a broad offering of high-quality primary cells, media, reagents and devices," said Andrew Winner, Product Manager for CellBio Services at Lonza Pharma Biotech & Nutrition. "CellBio Services has been established to expand this offering beyond the standard catalog products and beyond what’s currently available on the market. Our customers can now benefit from unique manufacturing and testing capabilities, as well as Lonza’s access to the broadest tissue inventories, to unlock the next level of their research options."
Lonza’s all-inclusive CellBio Services offering comprises:
- Cell-line expansion and banking – cell lines can be expanded up to 10e10 and the cells can be cryopreserved in the preferred format
- Media production – manipulation of Lonza’s catalog media products or production of new media, either in liquid or powder format
- Cell isolation – from a variety of tissues, including human, primate, porcine, canine, feline and murine
- Cell...
Further information can be found via the website www.lonza.com/cellbioservices
Interested in reading more?
The Scientist ARCHIVES
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
